Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Chronic Lymphoproliferative Disorder of Natural Killer Cells: Patient Characteristics, Laboratory Features, and Clinical Outcomes

Richard C. Godby, Kari G. Rabe, Steven R. Hwang, Hadiyah Audil, Susan L. Slager, Saad S. Kenderian, Neil E. Kay, Yucai Wang, Paul J Hampel, Sameer A. Parikh, Wei Ding, Min Shi

Blood (2023) 142 (Supplement 1): 4446.

https://doi.org/10.1182/blood-2023-182545

Published: 2023

Journal Articles

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

Blood (2023) 142 (Supplement 1): 3284.

https://doi.org/10.1182/blood-2023-181866

Published: 2023

Journal Articles

PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2

Blood (2023) 142 (Supplement 1): 3261.

https://doi.org/10.1182/blood-2023-177755

Published: 2023

Journal Articles

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Blood (2023) 142 (Supplement 1): 3271.

https://doi.org/10.1182/blood-2023-185076

Published: 2023

Journal Articles

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Blood (2023) 142 (Supplement 1): 3276.

https://doi.org/10.1182/blood-2023-183007

Published: 2023

Journal Articles

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Jansen N Seheult, Min Shi, Horatiu Olteanu, Gregory E Otteson, Michael M Timm, Matthew J Weybright, Pedro Horna

Blood (2023) 142 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2023-190275

Published: 2023

Journal Articles

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Blood (2023) 141 (9): 1036–1046.

https://doi.org/10.1182/blood.2021013489

Published: 2023

Includes: Supplemental data

Journal Articles

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Pedro Horna, Gregory Otteson, Min Shi, Jansen N. Seheult, Dragan Jevremovic, Horatiu Olteanu

Blood (2022) 140 (26): 2852–2856.

https://doi.org/10.1182/blood.2022017548

Published: 2022

Includes: Supplemental data

Journal Articles

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding

Blood (2022) 140 (Supplement 1): 12390–12392.

https://doi.org/10.1182/blood-2022-165508

Published: 2022

Journal Articles

Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021

Maymona Abdelmagid, Aref Al-Kali, Kebede H. Begna, William J. Hogan, Mark R. Litzow, Abhishek A. Mangaonkar, Mrinal M.M. Patnaik, Michelle A Elliott, Hassan B. Alkhateeb, Min Shi, Matthew Howard, Kaaren K. Reichard, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Blood (2022) 140 (Supplement 1): 9735–9736.

https://doi.org/10.1182/blood-2022-163450

Published: 2022

Journal Articles

Risk Factors and Prognosis Analysis of Patient-Specific HLA Genomic Loss Relapse Following ATG-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation

Hengwei Wu, Ji Min Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Guifang Ouyang, Xiaojun Xu, Xiao Haowen, He Huang, Yanmin Zhao

Blood (2021) 138 (Supplement 1): 3930.

https://doi.org/10.1182/blood-2021-147153

Published: 2021

Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

Blood (2021) 138 (Supplement 1): 1560.

https://doi.org/10.1182/blood-2021-151668

Published: 2021

Journal Articles

Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter's Syndrome (RS) and Progressive Chronic Lymphocytic Leukemia (CLL)

Shulan Tian, MS, PhD, Hanyin Wang, MD, Timothy G. Call, MD, Eric W. Klee, PhD, Minetta C. Liu, MD, Erik Jessen, PhD, Sameer A. Parikh, MD, Yucai Wang, MDPhD, Saad S. Kenderian, MB, ChB, Jose F. Leis, MD PhD, Min Shi, MDPhD, Eli Muchtar, MD, Daniel L. Van Dyke, PhD, Amber B. Koehler, PA-C, MS, Neil E. Kay, MD, Susan L. Slager, PhD, Esteban Braggio, PhD, Huihuang Yan, PhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138397

Published: 2020

Journal Articles

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Aishwarya Ravindran, MBBS, Andrew L. Feldman, MD, Rhett P. Ketterling, MD, Surendra Dasari, PhD, Karen Rech, MD, Ellen D. McPhail, MD, Paul J Kurtin, MD, Min Shi, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134547

Published: 2020

Journal Articles

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Paul J. Hampel, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Mithun Vinod Shah, MD PhD, Nabila Bennani, MD, Aref Al-Kali, MD, Kari G Rabe, Yucai Wang, MDPhD, Eli Muchtar, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MB, ChB, Amber B. Koehler, PA-C, MS, Susan M. Schwager, Daniel L. Van Dyke, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Min Shi, MDPhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-134586

Published: 2020

Journal Articles

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Ahmad Nanaa, Rama Nana, Zhuoer Xie, MD, Dragan Jevremovic, MD PhD, Phuong L. Nguyen, MD, Cynthia Hengel, Susan M. Geyer, PhD, Rong He, MD, David S. Viswanatha, MD, Michael M. Timm, Mohamed E Salama, MD, Min Shi, MDPhD, Patricia Greipp, DO, Hassan B. Alkhateeb, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142181

Published: 2020

Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Paul J. Hampel, MD, Timothy G. Call, MD, Kari G Rabe, Sara J. Achenbach, Eli Muchtar, MD, Saad S. Kenderian, MB, ChB, Yucai Wang, MDPhD, Amber B. Koehler, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Min Shi, MDPhD, Curtis A. Hanson, MD, Tait Shanafelt, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Wei Ding, MD PhD, Sameer A. Parikh, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137578

Published: 2020

Journal Articles

Impact of Deletion6q23 Identified By FISH in Patients with Chronic Lymphocytic Leukemia

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-139068

Published: 2020

Journal Articles

Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib

Hanyin Wang, MD, Shulan Tian, MS, PhD, Qing Zhao, Wendy Blumenschein, Jennifer H. Yearley, PhD, Charla R. Secreto, Sutapa Sinha, PhD, Timothy G. Call, MD, Yucai Wang, MDPhD, Sameer A. Parikh, MD, Saad S. Kenderian, MB, ChB, Rong He, MD, Jose F. Leis, MD PhD, Min Shi, MDPhD, Neil E. Kay, MD, Susan L. Slager, PhD, Esteban Braggio, PhD, Huihuang Yan, PhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136172

Published: 2020

Journal Articles

Central Nervous System (CNS) Involvement of Richter Transformation: A Single Center Experience

Yucai Wang, MDPhD, Marcella Tschautscher, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Neil E. Kay, MD, Patrick B. Johnston, Luis F. Porrata, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD, Stephen M. Ansell, MD PhD, Min Shi, MDPhD, Saad S. Kenderian, MB, ChB, Eli Muchtar, MD, Suzanne R. Hayman, MD, Amber B. Koehler, PA-C, MS, Jose F. Leis, MD PhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139769

Published: 2020

NARROW

Chronic Lymphoproliferative Disorder of Natural Killer Cells: Patient Characteristics, Laboratory Features, and Clinical Outcomes

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021

Risk Factors and Prognosis Analysis of Patient-Specific HLA Genomic Loss Relapse Following ATG-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter's Syndrome (RS) and Progressive Chronic Lymphocytic Leukemia (CLL)

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Impact of Deletion6q23 Identified By FISH in Patients with Chronic Lymphocytic Leukemia

Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib

Central Nervous System (CNS) Involvement of Richter Transformation: A Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only